Cystathionine Beta Synthase (CBS) is a pyridoxal phosphate (PLP)-dependent enzyme that catalyzes the condensation of serine and homocysteine to form cystathionine, a critical intermediate in the transsulfuration pathway. This enzymatic reaction represents the rate-limiting step in the conversion of homocysteine to cysteine, which is essential for the synthesis of glutathione (GSH), the primary cellular antioxidant 1. Beyond its canonical role in amino acid metabolism, CBS is a key producer of hydrogen sulfide (H₂S), a gasotransmitter with potent neuroprotective properties including anti-inflammatory, antioxidant, and anti-apoptotic effects 2.
The dual functionality of CBS—producing both cysteine for GSH synthesis and H₂S for cell signaling—makes it a crucial enzyme in maintaining neuronal health. CBS dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease, as well as the inherited metabolic disorder homocystinuria 3.
| Cystathionine Beta Synthase (CBS) |
|---|
| Protein Name | Cystathionine Beta Synthase |
| Gene | [CBS](/genes/cbs) |
| UniProt ID | [P35520](https://www.uniprot.org/uniprot/P35520) |
| PDB IDs | 1JBD, 1M54, 3O47, 5NHH |
| Molecular Weight | 55.5 kDa |
| Cofactor | Pyridoxal phosphate (PLP) |
| Subcellular Localization | Cytoplasm, Mitochondria |
| Expression | Ubiquitous, high in brain, liver, kidney |
| Associated Diseases | Homocystinuria, Alzheimer's Disease, Parkinson's Disease |
¶ Structure and Molecular Mechanism
¶ Domain Architecture
CBS possesses a sophisticated modular structure that enables its dual catalytic functions:
N-terminal Catalytic Domain (1-413 aa):
- Contains the pyridoxal phosphate (PLP) binding site
- Hosts the active site where the condensation reaction occurs
- The PLP cofactor forms a Schiff base with a conserved lysine residue (Lys-119)
- Catalyzes the β-replacement reaction: serine + homocysteine → cystathionine
Central heme-binding domain (250-353 aa):
- Contains a heme b cofactor that influences protein stability
- The heme iron is coordinated by Cys-272 and His-353
- Serves as a regulatory element affecting enzyme activity
- heme binding is unique to CBS among mammalian PLP-dependent enzymes
C-terminal Regulatory Domain (414-561 aa):
- Contains two tandem CBS domains (CBS1 and CBS2)
- Binds S-adenosylmethionine (SAM), a key metabolic signal
- SAM binding dramatically activates CBS (up to 10-fold)
- Forms a dimerization interface for tetramer formation
CBS forms a functional homodimer or tetramer in solution:
- Dimeric assembly: Each monomer contains N-terminal catalytic and C-terminal regulatory domains
- Tetramer formation: Dimers can further associate into tetramers, enhancing stability
- Allosteric regulation: SAM binding to C-terminal domains propagates conformational changes to the catalytic site
- Active site geometry: The PLP Schiff base is positioned for optimal catalysis with substrates
The CBS-catalyzed reaction proceeds through the following steps:
- Formation of external aldimine: PLP-bound Lys-119 is replaced by serine substrate
- ** Racemization/deprotonation**: The serine-PLP complex undergoes deprotonation
- Generation of quinonoid intermediate: Key catalytic intermediate forms
- Condensation with homocysteine: The activated serine attacks homocysteine
- Trans-sulfuration: Formation of cystathionine product
- Regeneration of internal aldimine: Lys-119 regenerates the PLP Schiff base
CBS activity is modulated by several post-translational mechanisms:
- S-adenosylmethionine (SAM) binding: Primary allosteric activator
- S-adenosylhomocysteine (SAH) inhibition: Product inhibitor
- Heme binding: Stabilizes the protein structure
- Oxidative modifications: Reactive oxygen species can inhibit activity
- Phosphorylation: Several kinases may regulate CBS activity
CBS serves as a critical metabolic hub connecting several essential biochemical pathways in the brain and other tissues.
CBS is the rate-limiting enzyme in the transsulfuration pathway, which converts homocysteine to cysteine:
- Methionine → Homocysteine: Methionine metabolism generates homocysteine
- Homocysteine + Serine → Cystathionine: CBS catalyzes this key condensation reaction
- Cystathionine → Cysteine: Cystathionine γ-lyase (CGL) converts cystathionine to cysteine
- Cysteine → Glutathione: Cysteine is used to synthesize glutathione (GSH)
This pathway is essential for:
- Maintaining redox homeostasis through GSH synthesis
- Regulating homocysteine levels (elevated homocysteine is neurotoxic)
- Providing cysteine for protein synthesis and taurine synthesis
Beyond its role in transsulfuration, CBS is a major producer of hydrogen sulfide (H₂S) in the brain:
H₂S biosynthesis pathways:
- CBS-mediated: Direct production from cysteine by CBS
- CGL-mediated: Cystathionine γ-lyase produces H₂S from cystathionine
- 3-MST mediated: 3-mercaptopyruvate sulfurtransferase in mitochondria
H₂S functions in the brain:
Antioxidant Defense:
- Activates Nrf2 transcription factor
- Increases expression of antioxidant enzymes (GPx, SOD, CAT)
- Scavenges reactive oxygen species (ROS)
- Protects against mitochondrial dysfunction 4
Anti-inflammatory Signaling:
- Inhibits NF-κB activation
- Reduces pro-inflammatory cytokine production
- Modulates microglial activation
- Attenuates neuroinflammation 5
Neuromodulation:
- Acts as a neurotransmitter/neuromodulator
- Modulates NMDA receptor activity
- Influences synaptic plasticity and memory formation
- Regulates cerebral blood flow
Mitochondrial Function:
- Preserves mitochondrial membrane potential
- Enhances electron transport chain complex activity
- Protects against mitochondrial permeability transition
- Promotes mitochondrial biogenesis
CBS-derived H₂S plays a role in maintaining blood-brain barrier (BBB) integrity:
- Tight junction protein expression
- Endothelial cell survival
- BBB permeability regulation
CBS dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms:
Oxidative Stress:
- Reduced GSH synthesis compromises antioxidant defenses 6
- Elevated homocysteine increases oxidative damage
- Impaired H₂S production reduces cellular protection
Amyloid Pathology:
- CBS deficiency exacerbates amyloid pathology in mouse models
- H₂S sulfhydrates GSK3β, inhibiting Tau hyperphosphorylation 7
- Reduced H₂S promotes amyloid-β toxicity
Synaptic Dysfunction:
- H₂S preserves synaptic protein function
- CBS deficiency impairs synaptic plasticity
- Memory consolidation is affected
Neuroinflammation:
- H₂S inhibits NF-κB pathway activation
- Reduced CBS activity increases inflammatory responses
- Microglial activation is modulated by H₂S
Therapeutic Implications:
- H₂S donors reduce cognitive deficits in AD models
- Betaine activates CBS and reduces amyloid-induced paralysis
- CBS/H₂S axis is a promising therapeutic target 8
CBS plays a protective role in dopaminergic neuron survival:
MPTP Toxicity:
- Impaired CBS/H₂S signaling contributes to MPTP-induced neurodegeneration 9
- H₂S protects against MPTP-induced complex I inhibition
- Dopaminergic neurons are particularly vulnerable to CBS dysfunction
Mitochondrial Protection:
- CBS-derived H₂S preserves mitochondrial complex IV activity 10
- Protects against mitochondrial ROS generation
- Maintains ATP production in dopaminergic neurons
Oxidative Stress:
- H₂S scavenges ROS in substantia nigra
- Protects dopaminergic neurons from oxidative damage
- Supports GSH synthesis for antioxidant defense
α-Synuclein Pathology:
- H₂S may reduce α-synuclein aggregation
- Protein sulfhydration prevents misfolding
- Autophagy modulation by H₂S
- Elevated homocysteine in HD patients
- CBS dysfunction contributes to transcriptional dysregulation
- H₂S neuroprotective effects in HD models
¶ Stroke and Vascular Dementia
CBS/H₂S axis dysfunction contributes to ischemic brain injury:
- H₂S pre-conditioning provides neuroprotection 11
- CBS activity correlates with stroke outcome
- Blood-brain barrier protection by H₂S
CBS deficiency causes classic homocystinuria:
Metabolic Consequences:
- Elevated homocysteine and methionine in blood and urine
- Reduced cystathionine and cysteine levels
- Impaired GSH synthesis
Neurological Manifestations:
- Intellectual disability if untreated
- Seizures
- Developmental delay
Systemic Features:
- Thromboembolic events
- Ectopia lentis
- Marfanoid habitus
Treatment:
- Vitamin B6 supplementation (some responsive mutations)
- Betaine supplementation
- Methionine-restricted diet
- Folate and vitamin B12 supplementation
Targeting the CBS/H₂S axis offers promising therapeutic approaches for neurodegenerative diseases.
Fast H₂S Donors:
- NaHS (Sodium hydrosulfide): Rapid H₂S release, used in experimental studies
- Na₂S (Sodium sulfide): Another fast-acting donor
- Short-lived effects, useful for acute studies
Slow H₂S Donors:
- GYY4137: Slow, sustained H₂S release
- AP39: Mitochondria-targeted H₂S donor
- JK-1: Fluorescent H₂S donor
Natural H₂S Donors:
- Garlic-derived compounds: Allicin, diallyl sulfide
- Sulforaphane: Activates CBS expression via Nrf2
¶ CBS Activators and Modulators
Direct CBS Activators:
- S-adenosylmethionine (SAM): Endogenous activator
- Betaine (trimethylglycine): Enhances CBS activity
- Vitamin B6 (pyridoxine): Essential cofactor
Indirect CBS Modulators:
- Nrf2 activators: Increase CBS expression
- HDAC inhibitors: Upregulate CBS transcription
- Antioxidants: Reduce oxidative inhibition
B Vitamin Complex:
- Vitamin B6 (pyridoxine): PLP cofactor precursor
- Vitamin B12 (cobalamin): Reduces homocysteine
- Folate: Converts homocysteine to methionine
- Combined B vitamin therapy reduces homocysteine
Clinical Considerations:
- B6-responsive vs. B6-non-responsive mutations
- Monitoring of homocysteine levels
- Personalized supplementation
- AAV-mediated CBS delivery: Viral vector gene therapy
- CRISPR-based editing: Correct pathogenic CBS mutations
- CBS expression modulation: Target regulatory elements
¶ Symptomatic and Disease-Modifying Strategies
Neurotrophic Factors:
- BDNF delivery to support neurons
- Neurotrophin-mediated protection
Anti-inflammatory Agents:
- NF-κB inhibitors
- Microglial modulators
Mitochondrial Protectants:
- CoQ10 and analogues
- Mitochondrial peptides
CBS interacts with several proteins to carry out its cellular functions:
- Cystathionine γ-lyase (CGL/CSE): Downstream enzyme in transsulfuration
- Methionine adenosyltransferase (MAT): Produces SAM
- S-adenosylhomocysteine hydrolase (SAHH): Regulates SAH levels
- Glutathione synthetase: Uses cysteine for GSH production
- γ-glutamylcysteine synthetase: Rate-limiting GSH synthesis step
- Nrf2: Transcription factor activated by H₂S
- NF-κB: Suppressed by H₂S signaling
- AMPK: Energy sensor modulated by H₂S
- GSK3β: Sulfhydration target in AD
- S-adenosylmethionine synthetase isoforms: Produce SAM
- Cystathionine β-synthase isoforms: Alternative splicing variants
- Heme oxygenase-1: Stress-responsive enzyme
- APP: Alzheimer's disease amyloid precursor
- α-Synuclein: Parkinson's disease protein
- Tau: AD neurofibrillary tangles
- Parkin: PD-linked E3 ubiquitin ligase
Cbs Knockout Mice:
- Embryonic lethality in complete knockouts
- Severe homocystinuria phenotype
- Oxidative stress and mitochondrial dysfunction
Cbs Heterozygous Mice:
- Partial CBS deficiency
- Elevated homocysteine
- Cognitive deficits in some models
Transgenic CBS Overexpression:
- Protection against oxidative stress
- Enhanced H₂S production
- Improved cognitive function
Homocysteine-induced neurodegeneration:
- Elevated homocysteine injection
- Mimics homocystinuria features
- Cognitive impairment
MPTP-induced PD model:
- CBS deficiency in substantia nigra
- H₂S levels reduced
- Dopaminergic neuron loss
| Model |
Species |
Key Phenotypes |
Relevance |
| Cbs-/- |
Mouse |
Embryonic lethality |
Essential enzyme |
| Cbs+/- |
Mouse |
Elevated Hcy, cognitive deficits |
Heterozygote model |
| MPTP |
Mouse |
PD-like neurodegeneration |
PD model |
| Homocysteine injection |
Rat |
Oxidative stress, neuronal loss |
Homocystinuria model |
- CBS regulation: What are the precise molecular mechanisms of CBS regulation in neurons?
- H₂S signaling: How does H₂S exert its neuroprotective effects at the molecular level?
- Therapeutic targeting: Can selective CBS activators be developed for CNS therapy?
- Biomarkers: Can CBS activity or H₂S levels serve as neurodegenerative disease biomarkers?
- Single-cell proteomics: Profile CBS in specific neuronal populations
- H₂S biosensors: Real-time visualization of H₂S in living cells
- iPSC models: Patient-derived neurons for disease modeling
- CRISPR screening: Identify genetic modifiers of CBS function
- H₂S donors in AD/PD clinical trials (various phases)
- Betaine supplementation trials
- Vitamin B therapy trials in neurodegenerative diseases